https://www.cbsnews.com/news/blood-pressure-medication-recall-aurobindo-pharma-valsartan-amlodipine-trace-amounts-carcinogen-chemical-ndea/
See link below for specific product information
Jan. 2, 2018
Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets.
The impurity involves a chemical called N-nitrosodiethylamine (NDEA), which the FDA describes as a "substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen."
To date, the company says it has not received any reports of patients suffering adverse effects related to the recall.
A full list of the recalled products is posted on the FDA's website.
•••••
No comments:
Post a Comment